Abstract:Traumatic brain injury (TBI) can induce traumatic axonal injury in the optic nerve, which is referred to as traumatic optic neuropathy (TON). TON occurs in up to 5% of TBI cases and leads to irreversible visual deficits. TON-induced phosphorylation of eIF2α, a downstream ER stress activator in the PERK pathway presents a potential point for therapeutic intervention. For eIF2α phosphorylation can lead to apoptosis or adaptation to stress. We hypothesized that dephosphorylation, rather than phosphorylation, of eIF2α would lead to reduced apoptosis and improved visual performance and retinal cell survival. Adult male mice were injected with Salubrinal (increases p-eIF2α) or ISRIB (decreases p-eIF2α) 60 minutes post-injury. Contrary to literature, both drugs hindered control animal visual function with minimal improvements in injured mice. Additionally, differences in eIF2α phosphorylation, antioxidant responses, and protein folding chaperones were different when examining protein expression between the retina and its axons in the optic nerve. These results reveal important compartmentalized ER stress responses to axon injury and suggest that interventions in the PERK pathway may alter necessary homeostatic regulation of the UPR in the retina.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: visual dysfunction and retinal cell death caused by traumatic optic neuropathy (TON) due to traumatic brain injury (TBI). Specifically, the author focuses on improving visual function after TON following TBI and the survival rate of retinal ganglion cells (RGCs) by intervening in the PERK - eIF2α pathway. ### Background and Problem Statement 1. **The Impact of Traumatic Brain Injury (TBI)**: - TBI affects approximately 2.9 million people annually (Taylor CA, 2017). - TBI not only causes direct primary injuries but also secondary effects, which usually lead to long - term complications (Ladak et al., 2019). - The impact of TBI is extensive, not limited to any specific brain control system, and each TBI case is different. 2. **Traumatic Optic Neuropathy (TON)**: - TON is a pathophysiological consequence of TBI, occurring in 5% of TBI cases and leading to irreversible visual defects (Steinsapir and Goldberg, 2011). - Symptoms of TON include progressive retinal thinning, decreased visual acuity, or complete blindness. - Long - term case studies have shown that visual changes in TON may last for 30 years after injury (Chen et al., 2017; Chan et al., 2019). 3. **ER Stress Response**: - TON induced by TBI leads to an increase in endoplasmic reticulum (ER) stress markers in the retina (Hetzer et al., 2021; Torrens et al., 2023). - The PERK pathway is more sensitive in chronic up - regulation and transient hypoxia intervention (Torrens et al., 2023), so the author chose to intervene in this pathway. ### Research Hypothesis - **Main Hypothesis**: - eIF2α dephosphorylation mediated by ISRIB can increase the survival rate of retinal ganglion cells and improve visual function. - Conversely, Salubrinal will increase the expression of apoptotic factors, leading to ER - mediated RGCs death. ### Experimental Design - **Animal Model**: - 8 - week - old male mice (C57BL/6J) were used to create a closed - head weight - drop TBI model. - One hour after injury, the mice received a single dose of Salubrinal (1.5 mg/kg), ISRIB (2.5 mg/kg), or a control drug (6.25% DMSO in sterile saline). - **Behavioral Test**: - The visual function of mice was evaluated by the optomotor response (OMR) test, and sinusoidal grating with different spatial frequencies was used to evaluate visual response and visual acuity. - **Western Blot Analysis**: - Changes in eIF2α phosphorylation levels, antioxidant responses, and protein - folding chaperones in the retina and optic nerve were detected. ### Main Findings - **Visual Function**: - ISRIB and Salubrinal did not significantly improve the overall visual response, but the performance of injured mice was improved at some spatial frequencies. - ISRIB showed better effects at a higher spatial frequency (0.39 cpd), but not significantly. - **eIF2α Phosphorylation**: - After injury, the p - eIF2α/total eIF2α ratio in the retina and optic nerve increased. - Salubrinal maintained a high level of p - eIF2α in the retina, but there was no significant change in the optic nerve. - ISRIB had no significant effect on the p - eIF2α level in the retina and optic nerve. - **Retinal Cell Survival**: - Both drugs failed to prevent the loss of RGCs and did not significantly affect the expression of apoptotic markers. - **Downstream Effectors**: - There are region - dependent differences in the expression of downstream effectors of the PERK pathway, such as nrf2, in the retina and optic nerve. - ISRIB and Salubrinal had a significant effect on nrf2 expression in the retina, but the opposite was true in the optic nerve. ### Conclusion

Targeting eIF2α in TBI-induced traumatic optic neuropathy: Effects of Salubrinal and the Integrated Stress Response Inhibitor

Transcorneal electrical stimulation promotes survival of retinal ganglion cells after optic nerve transection in rats accompanied by reduced microglial activation and TNF-α expression

The expression of NF-E2-related factor 2 in the rat brain after traumatic brain injury.

Traumatic Optic Neuropathy Is Associated with Visual Impairment, Neurodegeneration, and Endoplasmic Reticulum Stress in Adolescent Mice

[Type 1 neurofibromatosis in Tunisia: 66 cases].

Modulation of Post-Traumatic Immune Response Using the IL-1 Receptor Antagonist Anakinra for Improved Visual Outcomes

Neuroprotective Effects of Resatorvid Against Traumatic Brain Injury in Rat: Involvement of Neuronal Autophagy and TLR4 Signaling Pathway

Increased ER Stress After Experimental Ischemic Optic Neuropathy and Improved RGC and Oligodendrocyte Survival After Treatment With Chemical Chaperon

Torsion-Induced Traumatic Optic Neuropathy (TITON): A Physiologically Relevant Animal Model of Traumatic Optic Neuropathy

Optic nerve crush induces spatial and temporal gene expression patterns in retina and optic nerve of BALB/cJ mice

BDNF and cAMP are neuroprotective in a porcine model of traumatic optic neuropathy

Raloxifene Modulates Microglia and Rescues Visual Deficits and Pathology After Impact Traumatic Brain Injury

Attenuation of Activated eIF2α Signaling by ISRIB Treatment After Spinal Cord Injury Improves Locomotor Function

Therapeutic Targeting of Retinal Immune Microenvironment with CSF-1 Receptor Antibody Promotes Visual Function Recovery after Ischemic Optic Neuropathy.

An antioxidant and anti-ER stress combination therapy elevates phosphorylation of α-Syn at serine 129 and alleviates post-TBI PD-like pathology in a sex-specific manner in mice

An Antioxidant and Anti-ER Stress Combo Therapy Decreases Inflammation, Secondary Brain Damage and Promotes Neurological Recovery following Traumatic Brain Injury in Mice

Diffusion basis spectrum imaging detects subclinical traumatic optic neuropathy in a closed-head impact mouse model of traumatic brain injury

[Physician, patient and disease from the viewpoint of medical psychology].

Intravitreal Injection of Long-Acting Pegylated Granulocyte Colony-Stimulating Factor Provides Neuroprotective Effects via Antioxidant Response in a Rat Model of Traumatic Optic Neuropathy

RGC and Vision Loss From Traumatic Optic Neuropathy Induced by Repetitive Closed Head Trauma Is Dependent on Timing and Force of Impact

Endoplasmic reticulum stress and the unfolded protein response: emerging regulators in progression of traumatic brain injury